{"public_id":"cl_93417b175571765b3f06a19dbe68b07d","status":"active","superseded_by_public_id":null,"corpus_id":10389450,"text":"The initial concentration of serum monoclonal protein was a significant predictor of progression at 20 years.","confidence":0.95,"paper":{"corpus_id":10389450,"title":"A long-term study of prognosis in monoclonal gammopathy of undetermined significance.","url":"https://sah.borca.ai/papers/10389450"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.95,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_17ec984692df8c1282461828687b0fd7","name":"serum monoclonal protein concentration","description":"The amount of monoclonal protein measured in a patient's serum at diagnosis.","types":["biomarker","predictor"],"url":"https://sah.borca.ai/concepts/co_17ec984692df8c1282461828687b0fd7"},{"public_id":"co_2a63f6ea759a48c28b5ca92085518328","name":"progression","description":"Advancement from MGUS to overt myeloma or another related plasma-cell disorder.","types":["outcome"],"url":"https://sah.borca.ai/concepts/co_2a63f6ea759a48c28b5ca92085518328"},{"public_id":"co_8e536886c7f99d2174ed588c0a184caf","name":"monoclonal gammopathy of undetermined significance","description":"A plasma-cell disorder characterized by the presence of a monoclonal protein without overt malignant disease.","types":["condition"],"url":"https://sah.borca.ai/concepts/co_8e536886c7f99d2174ed588c0a184caf"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_93417b175571765b3f06a19dbe68b07d"}